Benjamin Brady

Dr

ADJUNCT SENIOR LECTURER, Undergraduate Teaching Alfred Hospital

EmailBenjamin.Brady@monash.edu

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Active

A Phase 3, randomised, double-blind study of adjuvant immunotherapy with Nivolumab versus placebo after complete resection of stage IIB/C Melanoma (CheckMate 76K: CHECKpoint pathway and nivoluMab clinical Trial Evaluation 76K).
Brady, B. & Baker, E.
1/04/20 → 31/12/22
Project: Research
A prospective, observational study in patients receiving adjuvant Nivolumab therapy for resected melanoma in Australia.
Brady, B. & Lai, L. H.
12/12/19 → 1/12/21
Project: Research

If you made any changes in Pure these will be visible here soon.